Our vision is to improve human health by evidence-based decision support tools for diagnosis and treatment through a better understanding of the specific nature of human motion and its consequences for mind and body. We need your support to continue to offer our tools and to publish our independent scientific results for the benefit of patients. Thank you.
Considerations for development of an evidence dossier to support the use ofmobile sensor technology for clinical outcome assessments in clinical trials published in Contemporary Clinical Trials, Elsevier on March 09, 2020
Mar 2020
7th Winter Symposium of The Human Motion Project - Preventive Treatments and Healthy Lifestyle Changes in Musculoskeletal and Related Diseases
Mar 2020
ENCePP last updated on 06/11/2019
Nov 2019
baretalk 2019 - August 7th, Munich
Aug 2019
DDT COA 000105, Actibelt® in Sarcopenia
Jun 2019
DDT COA 000106, Actibelt® in Multiple Sclerosis
Jun 2019
Human Perception of Verticality, Lateropulsion & Retropulsion in Neurological Disorders - May 10, 2019 in Bad Aibling, Germany
Apr 2019
KNIMS - Kompetenznetzwerk Immobilisationsbedingte Muskelstörungen - DLR Cologne March 8-9, 2019
Mar 2019
6th Winter Symposium of THE HUMAN MOTION PROJECT - Real World Walking Speed - Definition, Measurement, Validation and Regulatory Acceptance
Feb 2019
baretalk 2018 - August 7th, Munich
Aug 2018
5th Winter Symposium of THE HUMAN MOTION PROJECT - Novel Endpoints Generated by Mobile Accelerometry for Use in Phase III Clinical Trials
Mar 2018
Webinars on IMI2 Call 13 - Start Date 27/11/2017 End Date 15/12/2017
Dec 2017
IMI Call Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Nov 2017
baretalk 2017 - August 2nd, Munich
Aug 2017
Revision 6 of the ENCePP Guide on Methodological Standards in Pharmacoepidemiology is now available on the ENCePP website
Jul 2017
